Company
Board Member
2025-12-10–present
Board Member
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
The company reported in an 8-K filed July 15, 2026 that Ron Squarer resigned as director, effective July 15, 2026. The company reported in an 8-K filed December 10, 2025 that Ron Squarer was appointed Class II director, effective December 10, 2025.
“In accordance with the Merger Agreement, at the Effective Time, each of the directors of the Company (James R. Porter, Ph.D.; Grant C. Bogle; Michael L. Meyers, M.D., Ph.D.; Christy Oliger; Anna Protopapas; Ron Squarer; Sapna Srivastava, Ph.D.; and Cameron A. Wheeler, Ph.D.) resigned from his or her respective position as a member of the Company's board of directors, and any committee thereof.”
“On December 10, 2025, in accordance with the recommendation of the Nominating and Corporate Governance Committee ("NCG Committee") of the Board, the Board elected Ron Squarer as a member of the Board, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
Organization not stated
Board Member
SEC 8-K
2025-12-10–present
Organization not stated
Board Member
SEC 8-K
2025-12-10–2026-07-15
Recorded roles and call appearances connecting this person to public companies.
Company
Board Member
2025-12-10–present
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.